Flagship explainer
How EMERGENT BIOSOLUTIONS INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $743M | 100% |
| |
| Cost of revenue | $326M | 44% |
|
| $417M | 56% |
| |
| $100M | 13% |
| |
| Income before tax | $82.8M | 11% |
|
| Income tax | $30.2M | 4% |
|
| $52.6M | 7% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001367644-26-000015